What is the recommended dose of domperidone (antiemetic medication) syrup for a 2-year-old child weighing 9.780 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Domperidone Dosing for a 2-Year-Old Child Weighing 9.78 kg

For a 2-year-old weighing 9.78 kg, domperidone syrup should be dosed at 0.25 mg/kg per dose, given 3-4 times daily, which equals approximately 2.4-2.5 mg per dose (typically rounded to 2.5 mg per dose), with a maximum daily dose not exceeding 30 mg/day or 1 mg/kg/day. 1

Practical Dosing Calculation

  • Weight-based calculation: 9.78 kg × 0.25 mg/kg = 2.45 mg per dose 1
  • Practical dose: 2.5 mg per dose, administered 3-4 times daily 1
  • Maximum daily dose: 10 mg/day (2.5 mg × 4 doses) for this child, well below the 30 mg/day safety threshold 1

Syrup Formulation and Administration

  • Domperidone syrup is typically available as 1 mg/mL concentration 1
  • For 2.5 mg per dose: Administer 2.5 mL of syrup per dose 1
  • Timing: Give 15-30 minutes before meals and at bedtime if needed for 4 doses daily 2, 3
  • Frequency: Every 6-8 hours, with doses timed before feeding to maximize prokinetic effect 2, 4

Critical Safety Considerations

  • Cardiac monitoring: Although domperidone has minimal CNS penetration and lower extrapyramidal effects compared to metoclopramide, doses above 30 mg/day have been associated with cardiac arrhythmias in older patients 5
  • This child's maximum daily dose of 10 mg is well within safe parameters 5
  • Domperidone has been used successfully in pediatric populations without significant extrapyramidal side effects, unlike metoclopramide 2, 3
  • The peripheral dopamine antagonist action provides antiemetic and gastroprokinetic effects without crossing the blood-brain barrier readily 2, 3

Duration and Monitoring

  • Treatment duration should be limited to the shortest period necessary to control symptoms 1
  • Monitor for rare prolactin-related effects (galactorrhea, gynecomastia), though these are uncommon in short-term pediatric use 4
  • Assess clinical response after 2-4 weeks of therapy 4

Important Caveats

  • Regulatory status: Domperidone is not FDA-approved in the United States but is widely used in many other countries 6
  • The evidence base for pediatric domperidone dosing relies primarily on clinical experience and extrapolation from adult studies, as specific pediatric guidelines are limited 1
  • Always verify local formulary availability and regulatory approval status before prescribing 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.